accountBRISTOL, Tenn.--(Business Wire)-- King Pharmaceuticals, Inc. (NYSE:KG) announced today that it has licensed from Merck Santé S.A.S., an affiliate of Merck KGaA, Darmstadt, Germany, the exclusive rights to market and sell...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to King Pharmaceuticals Licenses Exclusive Rights to CYANOKIT® in U.S.
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account
